January 2026 FDA Recall Sodium Iodide I-131 by Radnostix
D-0389-2026 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Radnostix on January 26, 2026 for the product Sodium Iodide I-131. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0389-2026

Reason for Recall
Presence of Particulate Matter: Due to production issues
Initiated
01-26-2026
Reported
03-11-2026
Quantity
16 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Nationwide in the USA and Puerto Rico
Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.

Batch or Lot Expiration Information

Batch# Batch I012626R-01, Exp 02/09/2026

Affected Packages Involved in this Recall